Tempest Therapeutics, Inc. funding
Tempest Therapeutics, Inc., a biotechnology company based in Brisbane, CA, filed a Form D with the SEC on October 14, 2026 and reported $7.5M raised.
Amount raised$7.5M
Offering size$7.5M
Filed with the SECOctober 14, 2026
First saleSeptember 15, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise, Other
LocationBrisbane, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 14
Other health care rounds in California
BigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAdela, Inc.$12M · Oct 19BiotechnologyAbvc Biopharma, Inc.$3.4M · Nov 10BiotechnologyNeuvivo, Inc.$1.4M · Nov 13PharmaceuticalsGale Force Aesthetics, Inc.$800K · Oct 22Other Health CareTheravie Pharma, Inc.$750K · Oct 19Biotechnology